People

Songhwa Choi

vc.miraeassetcapital.comlinkedin.com

Songhwa Choi is identified in Mirae Asset Capital’s current public investment roster as BIO Investment Team — Sr. Manager. Published investment interests: Novel Therapeutics Platform, , Digital Therapeutics/Healthcare. Prior organizations named in the official profile include Hanmi Pharmaceuticals. The profile lists education in Stony Brook University, Ph.D. in Molecular and Cellular Biology; Seoul National University, Master of Pharmacy; Seoul National University, Bachelor of Pharmacy. The individual’s original named-card portrait and biography fields are independently sourced; no personal cash participation is inferred.